Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$419M |
| 2 |
Truist Financial
TFC
|
+$351M |
| 3 |
Mastercard
MA
|
+$218M |
| 4 |
PPL
PPL Corp
PPL
|
+$193M |
| 5 |
Cognizant
CTSH
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$592M |
| 2 |
IBM
IBM
|
+$320M |
| 3 |
Wells Fargo
WFC
|
+$306M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$290M |
| 5 |
Walt Disney
DIS
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.85% |
| 2 | Financials | 13.92% |
| 3 | Healthcare | 13.77% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
National Grid
NGG
$81.5B
| $11.7M | ﹤0.01% |
211,340
+125,949
| +147% | +$6.47M |
|
|
SRCI
1877
DELISTED
SRC Energy Inc
SRCI
| $11.7M | ﹤0.01% |
2,842,426
-925,333
| -25% | -$3.51M |
|
1878
ICF International
ICFI
$1.59B
| $11.7M | ﹤0.01% |
127,691
+16,899
| +15% | +$1.45M |
|
1879
Enanta Pharmaceuticals
ENTA
$383M
| $11.7M | ﹤0.01% |
189,317
-6,966
| -4% | -$432K |
|
|
OSG
1880
Octave Specialty Group
OSG
$221M
| $11.7M | ﹤0.01% |
541,630
-152,548
| -22% | -$3.13M |
|
1881
iShares Core MSCI Total International Stock ETF
IXUS
$60.8B
| $11.7M | ﹤0.01% |
188,701
-8,187
| -4% | -$491K |
|
1882
Box
BOX
$4.52B
| $11.6M | ﹤0.01% |
693,610
+95,631
| +16% | +$1.6M |
|
1883
iShares MSCI ACWI ETF
ACWI
$33.6B
| $11.6M | ﹤0.01% |
146,625
+40,247
| +38% | +$3.08M |
|
1884
Anika Therapeutics
ANIK
$288M
| $11.6M | ﹤0.01% |
223,931
-11,095
| -5% | -$644K |
|
|
HNGR
1885
DELISTED
Hanger Inc.
HNGR
| $11.6M | ﹤0.01% |
420,269
+262,095
| +166% | +$6.22M |
|
1886
Artivion
AORT
$1.42B
| $11.6M | ﹤0.01% |
427,750
+11,479
| +3% | +$282K |
|
1887
WisdomTree US MidCap Dividend Fund
DON
$4.13B
| $11.5M | ﹤0.01% |
303,488
+70,206
| +30% | +$2.6M |
|
1888
Douglas Dynamics
PLOW
$976M
| $11.5M | ﹤0.01% |
209,820
-24,250
| -10% | -$1.22M |
|
1889
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.74B
| $11.5M | ﹤0.01% |
113,841
+5,504
| +5% | +$555K |
|
|
CHNG
1890
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $11.5M | ﹤0.01% |
702,842
+462,725
| +193% | +$6.21M |
|
1891
Virtus Investment Partners
VRTS
$1.13B
| $11.5M | ﹤0.01% |
94,561
-3,820
| -4% | -$426K |
|
|
ARR
1892
Armour Residential REIT
ARR
$2.37B
| $11.5M | ﹤0.01% |
128,746
+2,426
| +2% | +$207K |
|
1893
Guardant Health
GH
$21.1B
| $11.5M | ﹤0.01% |
146,861
+13,884
| +10% | +$1M |
|
1894
Chord Energy
CHRD
$7.51B
| $11.5M | ﹤0.01% |
3,515,411
+77,285
| +2% | +$221K |
|
1895
Halozyme
HALO
$11.2B
| $11.4M | ﹤0.01% |
644,701
+1,234
| +0.2% | +$21.4K |
|
1896
Invesco S&P 500 Equal Weight ETF
RSP
$100B
| $11.4M | ﹤0.01% |
98,758
+27,484
| +39% | +$3.05M |
|
1897
Moderna
MRNA
$25.3B
| $11.4M | ﹤0.01% |
583,114
+82,269
| +16% | +$1.46M |
|
1898
Rush Enterprises Class A
RUSHA
$9.6B
| $11.4M | ﹤0.01% |
551,819
-70,655
| -11% | -$1.38M |
|
1899
Alkermes
ALKS
$8.23B
| $11.4M | ﹤0.01% |
558,311
-74,534
| -12% | -$1.48M |
|
1900
Red Rock Resorts
RRR
$3.76B
| $11.4M | ﹤0.01% |
474,680
-58,346
| -11% | -$1.3M |
|
Similar funds
Bank of New York Mellon's Q4 2019 Portfolio in Review
As of Q4 2019, Bank of New York Mellon held 4,341 positions worth $388B, up 6.4% from $364B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bank of New York Mellon's Q4 2019 filing shows 131 new, 1,843 increased, 1,854 reduced and 165 closed positions. Its largest new stake was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 1,648,268 shares worth $46M. The largest sale was Celgene Corp, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2019 buy was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 1,648,268 shares worth $46M.
- Bank of New York Mellon added most to Bristol-Myers Squibb in Q4 2019, an estimated $419M increase.
- Bank of New York Mellon's biggest Q4 2019 reduction was IBM, cutting an estimated $320M.
- Bank of New York Mellon fully exited Celgene Corp in Q4 2019, selling an estimated $592M.
- Bank of New York Mellon's ten largest holdings make up 16% of its $388B portfolio in Q4 2019.
- Bank of New York Mellon opened 131 new positions and closed 165 in Q4 2019.
- Bank of New York Mellon's portfolio value rose 6.4% quarter-over-quarter to $388B.
Based on Bank of New York Mellon's 13F filing for Q4 2019, filed 14 Feb 2020.